Magnetic resonance imaging for monitoring the effects of thalidomide on experimental human breast cancers.
about
Permeability to macromolecular contrast media quantified by dynamic MRI correlates with tumor tissue assays of vascular endothelial growth factor (VEGF).Evaluation of a novel macromolecular cascade-polymer contrast medium for dynamic contrast-enhanced MRI monitoring of antiangiogenic bevacizumab therapy in a human melanoma model.In vivo monitoring of sorafenib therapy effects on experimental prostate carcinomas using dynamic contrast-enhanced MRI and macromolecular contrast media.Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) in Preclinical Studies of Antivascular Treatments.Perfusion parameters of dynamic contrast-enhanced magnetic resonance imaging predict outcomes of hepatocellular carcinoma receiving radiotherapy with or without thalidomide.Correlative dynamic contrast MRI and microscopic assessments of tumor vascularity in RIP-Tag2 transgenic mice.
P2860
Magnetic resonance imaging for monitoring the effects of thalidomide on experimental human breast cancers.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Magnetic resonance imaging for ...... rimental human breast cancers.
@en
Magnetic resonance imaging for ...... rimental human breast cancers.
@nl
type
label
Magnetic resonance imaging for ...... rimental human breast cancers.
@en
Magnetic resonance imaging for ...... rimental human breast cancers.
@nl
prefLabel
Magnetic resonance imaging for ...... rimental human breast cancers.
@en
Magnetic resonance imaging for ...... rimental human breast cancers.
@nl
P2093
P2860
P1433
P1476
Magnetic resonance imaging for ...... rimental human breast cancers.
@en
P2093
Barbara Sennino
Bundit Chaopathomkul
Clemens C Cyran
David M Shames
Donald M McDonald
Michael F Wendland
Robert C Brasch
Victor S Rogut
P2860
P2888
P304
P356
10.1007/S00330-008-1111-X
P407
P577
2008-07-30T00:00:00Z